Veterinary Medicine Information website

Terivac

Authorised
  • Turkey rhinotracheitis virus, strain VCO3, Live
Download as PDF

Product identification

Medicine name:
Terivac
Active substance:
  • Turkey rhinotracheitis virus, strain VCO3, Live
Target species:
  • Turkey
Route of administration:
  • Nebulisation use
  • In drinking water/milk use
  • In drinking water use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain VCO3, Live
    199.53
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oral suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Turkey
      • Meat and offal
        0
        day
  • In drinking water/milk use
    • Turkey
      • Meat and offal
        0
        day
  • In drinking water use
    • Turkey
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01CD01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 106a/90
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 9/03/2022
Download